✦ LIBER ✦

Clinical Characteristics Predict Benefits From Eptifibatide Therapy During Coronary Stenting: Insights From the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) Trial

✍ Scribed by Joseph A. Puma; Lesan T. Banko; Karen S. Pieper; Terrence J. Sacchi; J. Conor O’Shea; Jean Pierre Dery; James E. Tcheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of one-year outcomes followin

✍ Marino Labinaz; Mina Madan; J.Conor O’Shea; Rakhi Kilaru; Wai Chin; Karen Pieper 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Outcomes of patients with acute coronary

✍ M. Labinaz; R. Kilaru; K. Pieper 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Effect of operator and institutional vol

✍ Mina Madan; Janarthan Nikhil; Anne S. Hellkamp; Karen S. Pieper; Marino Labinaz; 📂 Article 📅 2009 🏛 Pulsus Group Inc 🌐 English ⚖ 702 KB

Management of patients with acute corona

✍ A.M. Lincoff; R.A. Harrington; R.M. Califf 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB